In the last week, the Biotech industry is up 3.2%, with Valneva up 25%. However, the industry is down 19% over the past year. Earnings are forecast to grow by 24% annually.
Has the French Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 18 May 2024 | €3.3b | €502.3m | -€592,424,218.48 | 27.9x | -5.6x | 6.5x |
Mon, 15 Apr 2024 | €3.3b | €515.7m | -€629,475,775.73 | 28.4x | -5.2x | 6.3x |
Wed, 13 Mar 2024 | €3.1b | €567.7m | -€646,653,407.25 | 21.5x | -4.8x | 5.5x |
Fri, 09 Feb 2024 | €3.0b | €558.9m | -€674,927,750.18 | 22.4x | -4.4x | 5.4x |
Sun, 07 Jan 2024 | €3.2b | €594.3m | -€683,335,361.00 | 23.1x | -4.7x | 5.4x |
Tue, 05 Dec 2023 | €3.2b | €594.7m | -€685,255,395.00 | 21.7x | -4.6x | 5.3x |
Thu, 02 Nov 2023 | €3.1b | €803.5m | -€567,784,769.00 | 21x | -5.5x | 3.9x |
Sat, 30 Sep 2023 | €3.3b | €827.5m | -€579,145,511.00 | 14.2x | -5.8x | 4x |
Mon, 28 Aug 2023 | €3.7b | €818.2m | -€727,289,207.00 | 24.1x | -5.1x | 4.5x |
Wed, 26 Jul 2023 | €3.8b | €817.5m | -€734,744,130.00 | 24.5x | -5.2x | 4.6x |
Fri, 23 Jun 2023 | €3.9b | €819.7m | -€742,987,860.00 | 25.3x | -5.3x | 4.8x |
Sun, 21 May 2023 | €3.8b | €831.2m | -€761,674,629.00 | 26.1x | -4.9x | 4.5x |
Tue, 18 Apr 2023 | €3.5b | €878.2m | -€769,875,315.00 | 31.6x | -4.5x | 4x |
Thu, 16 Mar 2023 | €3.3b | €1.0b | -€470,273,558.00 | 9.7x | -7x | 3.2x |
Sat, 11 Feb 2023 | €3.7b | €1.0b | -€457,392,283.00 | 11.5x | -8.1x | 3.5x |
Mon, 09 Jan 2023 | €3.7b | €1.0b | -€455,883,646.00 | 12.1x | -8x | 3.5x |
Wed, 07 Dec 2022 | €3.5b | €1.0b | -€457,899,023.00 | 12.6x | -7.5x | 3.3x |
Fri, 04 Nov 2022 | €3.6b | €914.4m | -€705,389,452.00 | 16.5x | -5.1x | 3.9x |
Sun, 02 Oct 2022 | €3.2b | €923.3m | -€677,984,751.00 | 31x | -4.7x | 3.5x |
Tue, 30 Aug 2022 | €4.4b | €930.8m | -€751,667,630.00 | 115x | -5.8x | 4.7x |
Thu, 28 Jul 2022 | €4.4b | €985.5m | -€688,213,309.00 | 120.9x | -6.3x | 4.4x |
Sat, 25 Jun 2022 | €4.7b | €993.1m | -€693,029,894.00 | 126x | -6.7x | 4.7x |
Mon, 23 May 2022 | €4.7b | €991.3m | -€692,391,260.00 | 134.4x | -6.8x | 4.8x |
Wed, 20 Apr 2022 | €5.1b | €1.2b | -€489,700,261.00 | 3x | -10.5x | 4.2x |
Fri, 18 Mar 2022 | €5.5b | €950.8m | -€648,046,770.00 | 17.4x | -8.5x | 5.8x |
Sun, 13 Feb 2022 | €5.4b | €929.8m | -€675,308,815.00 | 3x | -7.9x | 5.8x |
Tue, 11 Jan 2022 | €6.1b | €931.7m | -€678,654,271.00 | 3.2x | -9x | 6.5x |
Thu, 09 Dec 2021 | €6.9b | €923.1m | -€680,995,918.00 | 2.7x | -10.1x | 7.4x |
Sat, 06 Nov 2021 | €6.5b | €921.3m | -€672,182,761.00 | 2.3x | -9.7x | 7.1x |
Mon, 04 Oct 2021 | €6.8b | €902.4m | -€738,666,719.00 | 2.6x | -9.2x | 7.5x |
Wed, 01 Sep 2021 | €7.7b | €899.6m | -€600,532,159.12 | 2.9x | -12.8x | 8.5x |
Thu, 08 Jul 2021 | €6.5b | €899.6m | -€600,532,159.12 | 2.8x | -10.8x | 7.2x |
-11.8x
How does French Biotech compare with similar industries?
FR Market | -0.42% | |
Healthcare | -2.18% | |
Biotech | 1.93% | |
Biotech | 1.93% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
VLA Valneva | €4.10 | 21.9% +€102.1m | -27.9% | PS3.7x | |
IVA Inventiva | €3.60 | 10.4% +€19.0m | 36.1% | PS8.1x | |
NANO Nanobiotix | €6.77 | 6.2% +€18.6m | 50.7% | PS8.8x | |
OSE OSE Immunotherapeutics | €7.41 | 9.8% +€14.2m | 96.0% | PS71.8x | |
ADOC Adocia | €9.55 | 10.7% +€14.2m | 167.5% | PS22.7x |